Figure 3From: ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesisErbB2 overexpression enhanced tumor size with IGF-IR induction after 14 days. H&E stained mammary sections 14 days after injection of RM11A+Dox injected mammary glands (a, b, c) and RM11A+Dox/ErbB2 injected mammary glands (d, e, f) are shown. Scale bars: 1 mm for (a-f). Quantification of tumor area is presented in (h). Asterisk = p < 0.05.Back to article page